Class / Patent application number | Description | Number of patent applications / Date published |
536054000 | Sulfur containing | 14 |
20110190486 | SULFONAMIDE DERIVATIVES OF POLYCYCLIC DYES USED FOR ANALYTICAL APPLICATIONS - The invention concerns the production of quinoline compounds containing sulfonic acid groups, the said quinoline compounds and their conversion into dyes containing sulfonic acid groups. The dyes according to the invention are used especially to label analytes, for example to label biomolecules. | 08-04-2011 |
20110319608 | PROCESS FOR PREPARING A MIXED SALT OF GLUCOSAMINE SULFATE AND AN ALKALI METAL CHLORIDE - The present invention relates to a process for preparing a mixed salt of glucosamine sulfate and an alkali metal chloride. The process comprises the consecutive steps of:
| 12-29-2011 |
20120208993 | SYNTHETIC HEPARIN TRISACCHARIDES - Preparation and use of synthetic trisaccharides useful for the preparation of synthetic heparinoids. | 08-16-2012 |
20120253029 | PROCESS FOR THE PREPARATION OF HIGHLY O-SULFATED EPIMERIZED DERIVATIVES OF K5 POLYSACCHARIDE AND INTERMEDIATES THEREIN - A new method is described for the oversulfation of epiK5-N-sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which, by subsequent N-sulfation, provides new epiK5-N,O-oversulfate-derivatives with a sulfation degree of at least 4, basically free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field. Also described are new low molecular weight epiK5-N-sulfates useful as intermediates in the preparation of the corresponding LMW-epiK5-N,O-oversulfate-derivatives. | 10-04-2012 |
20120309955 | ZWITTERIONIC POLYSACCHARIDES FOR PROMOTION OF IMMUNE SYSTEM MATURATION AND HEALTH - Certain zwitterionic polysaccharides, including those naturally expressed by commensal | 12-06-2012 |
20130018181 | Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof - The present invention provides a novel and highly stereoselective process for preparing gemcitabine, which is suitable for industrial production, wherein, it includes the following reactions. Additionally, the invention discloses the key intermediates. The definition for the groups of G1, G2, G3, G4, and G5 are described in the specification. | 01-17-2013 |
20130035481 | PRODUCTION OF 6'-O-SIALYLLACTOSE AND INTERMEDIATES - The present invention relates to a method for preparation of the trisaccharide 6′-0-sialyllactose (formula (I)) or salts thereof as well as intermediates in the synthesis and for the use of 6′-0-sialyllactose salts in pharmaceutical or nutritional compositions. | 02-07-2013 |
20130197210 | COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES - The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex. Both the polymer of the particulate composite and the complexing agent may be used to introduce functionality into the therapeutic composition. A therapeutic composition of the invention may be used to deliver the therapeutic agent and to treat various disorders. The invention also relates to a method of preparing a composition of the present disclosure. The invention further relates to a method of delivering a therapeutic agent, using the composition of the present disclosure, where a therapeutically effective amount of a therapeutic composition of the invention may be administered to a mammal (e.g. person or animal) in recognized need of the therapeutic. | 08-01-2013 |
20130225802 | PROCESS FOR OBTAINING CHONDROITIN SULPHATED AT THE 4- OR 6- POSITIONS OF N-ACETYL-GALACTOSAMINE RESIDUES - Disclosed is a process for the production of chondroitin sulphate, wherein N-acetyl-galactosamine residues sulphated at the 4- or 6-positions are present on the same polysaccharide chain. | 08-29-2013 |
20140094600 | Process for preparation of ketolide compounds - A process for the preparation of compound of Formula (I) is provided. Formula-I | 04-03-2014 |
20140296506 | GLUCOPYRANOSIDE COMPOUND - A compound of the formula: | 10-02-2014 |
20140316129 | PROCESS FOR THE PREPARATION OF HIGHLY O-SULFATED, EPIMERIZED DERIVATIVES OF K5 POLYSACCHRIDE AND INTERMEDIATES THEREIN - A new method is described for the oversulfation of epiK5-N-sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which, by subsequent N-sulfation, provides new epiK5-N,O-oversulfate-derivatives with a sulfation degree of at least 4, basically free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field. Also described are new low molecular weight epiK5-N-sulfates useful as intermediates in the preparation of the corresponding LMW-epiK5-N,O-oversulfate-derivatives. | 10-23-2014 |
20150038694 | GLUCOSE DERIVATIVES BOUND TO ARSENIC FOR USE IN THE TREATMENT OF TUMOUR - A family of sugar-based molecules for therapeutic use, includes compounds with a structure having at least one sugar molecule with carrier function, bound to arsenic having active principle function, allowing the selective therapeutic treatment of tumoral pathologies and not, distinguished by a high cellular metabolism and, consequently, by a high glucose consumption. Based on the preferential glucose absorption according to the Warburg effect, the compounds are adapted to penetrate inside tumoral cells and not, distinguished by a high cellular metabolism, via the glucose molecule integrated in their structure, so as to determine the selective therapeutic treatment of the cells and, consequently, of the pathologies deriving therefrom, by the arsenic molecule chemically bound to above mentioned glucose molecule. Processes for the production of synthetic sugar-based compounds and extracted sugar-based compounds, produced from natural sources are also described. | 02-05-2015 |
20150360147 | Benzimidazole Compounds And Their Use As Chromatographic Ligands - The present invention provides a new method for isolation and/or purification of immunoglobulins from a solution containing one or more immunoglobulins using a solid phase matrix represented by the formula: M-SP-L, wherein M is designates a matrix backbone, SP designates a spacer and L designates a substituted benzimidazole ligand. | 12-17-2015 |